Literature DB >> 21514479

The challenges of oral agents as antineoplastic treatments.

Barbara A Given1, Sandra L Spoelstra, Marcia Grant.   

Abstract

OBJECTIVES: Given the increasing use of oral antineoplastic agents in cancer management, patient adherence is critical to successful treatment outcomes. This article reviews the scope of the problem and issues of adherence to oral antineoplastic agents. DATA SOURCES: Research-based and other articles, newsletters, and conference presentations.
CONCLUSION: Suboptimal adherence to oral antineoplastic agents is a significant clinical problem that may result in disease or treatment complications, adjustment in treatment regimen, disease progression, and premature death. IMPLICATIONS FOR NURSING PRACTICE: Healthcare providers need to monitor and facilitate adherence by identifying barriers and implementing strategies to assure adherence, and therefore, improve clinical outcomes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514479     DOI: 10.1016/j.soncn.2011.02.003

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  21 in total

Review 1.  A Systematic Review of Adherence to Oral Antineoplastic Therapies.

Authors:  Joseph A Greer; Nicole Amoyal; Lauren Nisotel; Joel N Fishbein; James MacDonald; Jamie Stagl; Inga Lennes; Jennifer S Temel; Steven A Safren; William F Pirl
Journal:  Oncologist       Date:  2016-02-26

Review 2.  Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax.

Authors:  Madeline Waldron; Allison Winter; Brian T Hill
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

3.  Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma.

Authors:  Masako Shomura; Tatehiro Kagawa; Koichi Shiraishi; Shunji Hirose; Yoshitaka Arase; Jun Koizumi; Tetsuya Mine
Journal:  World J Hepatol       Date:  2014-09-27

4.  Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study.

Authors:  Claire C Conley; McKenzie McIntyre; Nicole A Pensak; Filipa Lynce; Deena Graham; Roohi Ismail-Khan; Katherine Lopez; Susan T Vadaparampil; Suzanne C O'Neill
Journal:  Breast Cancer Res Treat       Date:  2022-01-07       Impact factor: 4.872

5.  Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial.

Authors:  Molly E Ream; Emily A Walsh; Jamie M Jacobs; Chloe Taub; Marc Lippman; Natasha Schaefer-Solle; Steven A Safren; Michael H Antoni
Journal:  Breast Cancer Res Treat       Date:  2021-08-19       Impact factor: 4.624

Review 6.  Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.

Authors:  M T E Puts; H A Tu; A Tourangeau; D Howell; M Fitch; E Springall; S M H Alibhai
Journal:  Ann Oncol       Date:  2013-11-26       Impact factor: 32.976

Review 7.  Oral Oncolytic Agents--A Need for Research to Enhance Patient Centeredness?

Authors:  Barbara A Given
Journal:  Cancer Nurs       Date:  2016 Jan-Feb       Impact factor: 2.592

8.  How are health literacy principles incorporated into breast cancer chemotherapy education? A review of the literature.

Authors:  Pearman D Parker; Sue P Heiney; Daniela B Friedman; Tisha M Felder; Robin Dawson Estrada; Eboni Herbert Harris; Swann Arp Adams
Journal:  J Nurs Educ Pract       Date:  2018-01-16

9.  Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life.

Authors:  Jamie M Jacobs; Molly E Ream; Nicole Pensak; Lauren E Nisotel; Joel N Fishbein; James J MacDonald; Joanne Buzaglo; Inga T Lennes; Steven A Safren; William F Pirl; Jennifer S Temel; Joseph A Greer
Journal:  J Natl Compr Canc Netw       Date:  2019-03-01       Impact factor: 11.908

10.  Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life.

Authors:  Hanneke Poort; Jamie M Jacobs; William F Pirl; Jennifer S Temel; Joseph A Greer
Journal:  Palliat Support Care       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.